Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.

Our Armacoin GZM coin is specially designed for advertising companies, various media, various greetings registered on the basis of blockchain. Each new message will not be overwritten by the previous one, but will be supplemented. These advertisers can be quite a lot and each of them will receive a payment for their advertising message. The cost of this one message will be 1 GZM. A specific function and variable were added in this coin. The function «Set-Messange» and the global variable «Messange» that is permanently stored in the blockchain. The «SetMessange» function adds a line to the «Messange» function and the 1 GZM is removed from the account of the one who calls this function and transfers this 1 GZM to the advertiser's account. This coin is like a prototype of a Billboard, where the owners of this token, that is, advertisers, can place a message in the contract line for only 1 GZM. The advertiser can place this message on the billboards in different cities, on websites and all visitors will see what is specified in the global parameter of the messange. This coin was created on the ERC-20 contract. The total number of issued and coins for mining does not exceeds 1 billion. The mining of this coin is also unique because it allows to generate GZM tokens with low power renewable energy. This leaves most of the green energy to use for the network, while the miner can use the opportunity to acquire new tokens. We are also developing applications for this smart contract and will give the opportunity to mine these tokens using renewable energy sources, various gadgets with installed pedometers apps, electric vehicles, fitness bracelets and much more. Everything will be done for environmentally friendly and safe mining, as well as for the stimulation of a healthy lifestyle of the people living on our planet. We will encourage everyone who cares about the purity and ecology of our planet.

This exchange allows transmission of encrypted and secure documentation, restricting access to third parties and offering access management to these creditable transfers, through an auditable, verifable and secure P2P transaction. These transmissions will be made through a distributed network of nodes located in the main European DPCs, guaranteeing 24x7 availability of information as well as protection against information loss thanks to the redundancy of our distributed network.

Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.

UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.